Showing results (21-30 of 223) with videos related to
Sort By:
Pageof 23
Journal of Liver Cancer|June 29, 2023
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular CarcinomaSu Jong Yu, Tim F GretenJournal of Hepatology|January 20, 2020
Gut microbiome in HCC - Mechanisms, diagnosis and therapyRobert F Schwabe, Tim F GretenNature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh KorangyCellular & Molecular Immunology|November 25, 2020
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cellsBenjamin Ruf, Bernd Heinrich, Tim F GretenHepatology (Baltimore, Md.)|November 1, 2012
Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapiesAustin Duffy, Julia Wilkerson, Tim F GretenCellular Immunology|January 28, 2021
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic targetChi Ma, Qianfei Zhang, Tim F GretenThe FEBS Journal|September 1, 2017
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytesChi Ma, Qianfei Zhang, Tim F GretenCellular and Molecular Life Sciences : CMLS|October 3, 2014
Immunogenicity of necrotic cell deathJaba Gamrekelashvili, Tim F Greten, Firouzeh KorangyDigestive Diseases (Basel, Switzerland)|October 31, 2012
Cellular immune suppressor mechanisms in patients with hepatocellular carcinomaFei Zhao, Firouzeh Korangy, Tim F GretenCancer|January 24, 2023
Top advances of the year: Hepatobiliary cancersKelley L Coffman-D'Annibale, Tim F GretenPageof 23